PARIS — French drug maker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8% in a its large-scale and final clinical trial.
Employees work in the cell-culture unit at the French drug maker Sanofi Pasteur's vaccine unit plant in Neuville-sur-Saone, near Lyon, in this March 14, 2014 file picture. The first vaccine against dengue fever, from France's Sanofi, reduced disease cases by 60.8% in a its large-scale and final clinical trial. (Reuters photo)
Sanofi has invested more than 1.3 billion euros ($1.7 billion) in the project, undertaking two decades of research on the world's fastest-growing tropical disease. In 2013, Thailand alone saw more than 120,000 cases and an estimated 120 deaths.
Keep up-to-date with the latest on coup d'etat with Bangkok Post SMS News. Call *451391000 to subscribe – 39 baht/month (7 days free, available in Thailand only) Bangkok Post SMS News: Deliver only trustworthy news on SMS
This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.